Brainstorm Cell Therapeutics
(OTC) BCLI
Brainstorm Cell Therapeutics Financials at a Glance
Market Cap
$9.74M
Revenue (TTM)
$849.00K
Net Income (TTM)
$10.85M
EPS (TTM)
$-1.46
P/E Ratio
-0.60
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.91
Volume
9,422
Open
$0.83
Price
$0.91
Volume
9,422
Open
$0.83
Previous Close
$0.88
Daily Range
$0.83 - $0.91
52-Week Range
$0.46 - $0.91
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.91
Volume
9,422
Open
$0.83
Previous Close
$0.88
Daily Range
$0.83 - $0.91
52-Week Range
$0.46 - $0.91
BCLI News
BCLI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Brainstorm Cell Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
27
CEO
Chaim Lebovits
Website
www.brainstorm-cell.comHeadquarters
New York City, NY 10019, US
BCLI Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
-13%
Net Income Margin
-13%
Return on Equity
0%
Return on Capital
1%
Return on Assets
-12%
Earnings Yield
-1.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.74M
Shares Outstanding
11.03M
Volume
9.42K
Short Interest
0.00%
Avg. Volume
25.72K
Financials (TTM)
Gross Profit
$849.00K
Operating Income
$11.69M
EBITDA
$11.31M
Operating Cash Flow
$9.09M
Capital Expenditure
$0.00
Free Cash Flow
$9.09M
Cash & ST Invst.
$187.00K
Total Debt
$720.00K
Brainstorm Cell Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$9.74M
N/A
Market Cap/Employee
$360.64K
N/A
Employees
27
N/A
Net Income
$2.11M
+22.2%
EBITDA
$2.00M
+33.1%
Quarterly Fundamentals
Net Cash
$321.00K
+52.3%
Accounts Receivable
$80.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$50.00K
-81.5%
Short Term Debt
$377.00K
-33.9%
Return on Assets
-12.44%
N/A
Return on Invested Capital
1.34%
N/A
Free Cash Flow
$1.10M
+66.6%
Operating Cash Flow
$1.10M
+66.6%